Montis Financial’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$948K Sell
3,625
-65
-2% -$16.7K 0.2% 66
2026
Q2
$929K Buy
3,690
+303
+9% +$65.2K 0.19% 67
2026
Q1
$737K Buy
3,387
+98
+3% +$21.7K 0.15% 73
2025
Q4
$752K Hold
3,289
– – 0.15% 74
2025
Q3
$762K Buy
3,289
+572
+21% +$116K 0.18% 77
2025
Q2
$504K Sell
2,717
-112
-4% -$20.8K 0.14% 85
2025
Q1
$593K Buy
2,829
+1
+0% +$194 0.17% 79
2024
Q4
$503K Buy
2,828
+186
+7% +$34.2K 0.16% 87
2024
Q3
$522K Buy
+2,642
New +$493K 0.19% 66
2021
Q3
– Sell
-2,407
Closed -$271K – 65
2021
Q2
$271K Hold
2,407
– – 0.22% 56
2021
Q1
$261K Hold
2,407
– – 0.24% 55
2020
Q4
$247K Hold
2,407
– – 0.25% 56

Other funds holding ABBV

Montis Financial's ABBV Position: Q3 2026 in Review

Montis Financial reduced its AbbVie (ABBV) stake by 1.8% in Q3 2026, selling an estimated $16.7K and leaving 3,625 shares worth $948K. The position accounts for 0.2% of the portfolio, ranked #66.

Montis Financial first reported a position in ABBV in Q4 2020 and has held it in 12 quarters since. 4,281 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Montis Financial held 3,625 shares of AbbVie worth $948K as of Q3 2026.
  • Montis Financial sold 65 AbbVie shares in Q3 2026, an estimated $16.7K.
  • AbbVie made up 0.2% of Montis Financial's portfolio in Q3 2026, its #66 holding.
  • Montis Financial first reported a position in AbbVie in Q4 2020 and has held it in 12 quarters since.
  • 4,281 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Montis Financial's 13F filing for Q3 2026, filed 4 Nov 2026.